Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

172 ta ish

Ish: A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

  1. Toward the Definition of the Mechanism of Action of Silymarin: Activities Related to Cellular Protection From Toxic Damage Induced by Chemotherapy

    Maria Cristina Comelli, U. Mengs, Carl Christoph Schneider +1

    Sharh maqola20074 iqtibos
    ABI

  2. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

    Peter Surai

    Sharh maqola20154 iqtibos
    ABI

  3. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP

    W. Zhu

    Maqola20014 iqtibos
    ABI

  4. Silybin and Silymarin - New and Emerging Applications in Medicine

    Radek Gažák, Daniela Walterová, Vladimı́r Křen

    Sharh maqola20074 iqtibos
    ABI

  5. Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity

    Michaela Pyszková, Michal Biler, David Biedermann +11

    Maqola20154 iqtibos
    ABI

  6. Preparation, Pharmacokinetics and Body Distribution of Silymarin-Loaded Solid Lipid Nanoparticles After Oral Administration

    Jun He, Shi-xiang Hou, Weigen Lu +2

    Maqola20074 iqtibos
    ABI

  7. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells

    Tiancong Wu, Wen Liu, Wenjie Guo +1

    Maqola20164 iqtibos
    ABI

  8. Silymarin for Liver Disease

    Ludovico Abenavoli, Nataša Milić

    Bob20174 iqtibos
    ABI

  9. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells

    Lenka Roubalová, Albena T. Dinkova‐Kostova, David Biedermann +3

    Maqola20174 iqtibos
    ABI

  10. Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability

    Amrita Nagi, Babar Iqbal, Shobhit Kumar +3

    Maqola20174 iqtibos
    ABI

  11. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: Biochemical evaluation of anti-inflammatory, antiapoptotic, and antiautophagic properties

    Fatih Mehmet Kandemır, Sefa Küçükler, Cüneyt Çağlayan +3

    Maqola20174 iqtibos
    ABI

  12. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies

    Haneen Amawi, Noor Hussein, Chandrabose Karthikeyan +7

    Maqola20174 iqtibos
    ABI

  13. Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics

    Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan +8

    Sharh maqola20184 iqtibos
    ABI

  14. Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells

    Maryam Mombeini, Ghasem Saki, Layasadat Khorsandi +1

    Maqola20184 iqtibos
    ABI

  15. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases

    Abdoh Taleb, Khalil Ali Ahmad, Awais Ullah Ihsan +6

    Sharh maqola20184 iqtibos
    ABI

  16. Silymarin Nanoformulation as Potential Anticancer Agent in Experimental Ehrlich Ascites Carcinoma-Bearing Animals

    Mohamed El‐Far, Neven Salah, Alaa Essam +2

    Maqola20184 iqtibos
    ABI

  17. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization

    Abid Mehmood Yousaf, Usman Rashid Malik, Yasser Shahzad +2

    Maqola20184 iqtibos
    ABI

  18. Selective Synthesis of 3-O-Palmitoyl-Silybin, a New-to-Nature Flavonolignan with Increased Protective Action against Oxidative Damages in Lipophilic Media

    Samantha Drouet, Joël Doussot, Laurine Garros +6

    Maqola20184 iqtibos
    ABI

  19. Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin

    Ahmed H. Ibrahim, Emil Rosqvist, Jan‐Henrik Smått +5

    Maqola20194 iqtibos
    ABI

  20. Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation

    Sarah Nasr, Maha M. A. Nasra, Heba A. Hazzah +1

    Maqola20194 iqtibos
    ABI

  21. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review

    Vahid Soleimani, Parisa Sadat Delghandi, Seyed Adel Moallem +1

    Sharh maqola20194 iqtibos
    ABI

  22. A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts

    Alena Rajnochová Svobodová, Eva Gabrielová, Jitka Ulrichová +3

    Maqola20194 iqtibos
    ABI

  23. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art

    Alfonso Di Costanzo, Ruggero Angelico

    Sharh maqola20194 iqtibos
    ABI

  24. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer

    Tahereh Hosseinabadi, Zahra Lorigooini, Maryam Tabarzad +4

    Sharh maqola20194 iqtibos
    ABI

  25. Inhibition of urinary bladder cancer cell proliferation by silibinin

    Tatiane Martins Barcelos Barros, Ana Paula Braga Lima, Tamires Cunha Almeida +1

    Maqola20204 iqtibos
    ABI